Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

There are no data comparing outcomes of patients treated with ceftazidime-avibactam versus comparators for carbapenem-resistant Enterobacteriaceae infections. At our center, ceftazidime-avibactam treatment of carbapenem-resistant Klebsiella pneumoniae bacteremia was associated with higher rates of c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Shields, Ryan K., Nguyen, M. Hong, Chen, Liang, Press, Ellen G., Potoski, Brian A., Marini, Rachel V., Doi, Yohei, Kreiswirth, Barry N., Clancy, Cornelius J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527595/
https://ncbi.nlm.nih.gov/pubmed/28559250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00883-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires